Read the latest positive news, breakthroughs, and inspiring stories about drug pricing, curated daily by BrightWire.
England's National Health Service will now provide a breakthrough breast cancer treatment to 1,000 women after resolving a years-long pricing dispute with AstraZeneca. The decision follows a historic U.S.-U.K. drug pricing agreement that's making lifesaving treatments more accessible.
Nine pharmaceutical companies just pledged to sell medications to Americans at prices matching the lowest rates in other wealthy nations. The agreements also include commitments to strengthen U.S. drug manufacturing and boost national medical stockpiles.
A global health agency discovered that switching away from oil-based ingredients could cut HIV medication costs by up to 15% while helping the planet. The finding offers hope for making essential medicines more affordable and sustainable.
Colorado just became the second state approved to bring prescription medications from Canada, potentially lowering costs for residents struggling with high drug prices. The FDA's approval marks another step toward making medicine more affordable for Americans.
The Trump administration just proposed a fix to stop drug companies from dodging Medicare price negotiations with a sneaky loophole. The change could save millions of seniors money on prescriptions starting in 2029.
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.
Maryland just became one of the first states to cap the price of a blockbuster diabetes drug, potentially saving millions while making lifesaving medication more affordable. The move could spark a nationwide shift in how states tackle soaring prescription costs.
Maryland just became one of the first states to put a hard limit on prescription drug prices, slashing the cost of a common diabetes medication. Starting January 2027, patients and government programs will pay no more than $204 for a month's supply of Jardiance.
A new bipartisan bill aims to cap insulin costs at $35 per month for millions with private insurance, building on Medicare protections already in place. The legislation also tackles pharmacy middlemen and aims to boost competition for the life-saving drug.
Consumer advocates are asking the government to authorize cheaper versions of popular weight loss and diabetes medications that millions of Americans can't afford. The move could help patients nationwide access drugs that have been out of reach due to high prices.
Wealthy countries are increasingly using special licenses to make patented drugs affordable for their citizens. A new study shows this practice jumped from 15% to 54% of all such licenses worldwide in just one decade.